Explorating the mechanism of Epimedii folium-Rhizoma drynariae herbal pair promoted bone defects healing through network pharmacology and experimental studies
Shan Shan Lei,Xiao Wen Huang,Lin Zi Li,Xu Ping Wang,Yang Zhang,Bo Li,Dan Shou
DOI: https://doi.org/10.1016/j.jep.2023.117329
IF: 5.195
2023-11-02
Journal of Ethnopharmacology
Abstract:Ethnopharmacological relevance Bone defects are difficult to treat and have a high incidence of nonunion. The Epimedii folium - Rhizoma drynariae herbal pair (EDP) is a traditional Chinese medicine (TCM) used for treating bone diseases. However, the mechanisms by which EDP promotes osteogenesis or bone formation remain largely unclear. Aim of the study : This study aimed to investigate the mechanism of EDP promoted bone formation in bone defects using network pharmacology and experiments. Materials and methods The chemical components of EDP were analyzed by UHPLC-MS. The hub target and pathway enrichment analysis was conducted using molecular docking or network pharmacology. The pharmacological actions of EDP were determined by μCT and histopathology examination using a bone defect rat model. The effects of EDP on the mRNA expression of Bmp2 , Smad2/5 , Runx2 , and Alp genes were measured by RT-PCR, while changes in the protein expressions of BMP2, COL1A1, SPP1, ALP, and RUNX2in the tibia tissues of the rats in response to EDP were analyzed by immunohistochemical staining or Western blot. We also performed cell viability assays, Alizarin Red and ALP staining assays, and RT-PCR to better understand how EDP affected osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs). Results Identified 14 key compounds and 47 hub targets of EDP that may be involved in promoting osteogenesis to repair bone defects. And the BMP/Smad/Runx2 pathway was likely the key pathway through which EDP promoted bone defects repairing. The results of in vivo rat experiments indicated that EDP effectively promoted tibia repair in the model rats and activated the BMP/Smad/Runx2 pathway in the tibia tissue, with upregulating Bmp2 , Bmpr1α , Smad2/5 , Runx2 , and Alp genes, and increased the protein expression of BMP2, COL1A1, RUNX2, and ALP. In vitro , EDP was found to increase the proliferation, differentiation, and mineralization in BMSCs- and also up-regulated the expression of key genes in the BMP/Smad/Runx2 pathway. Conclusion This study highlighted the ability of EDP to promote the osteogenic differentiation to enable bone repair by activating the BMP/Smad/Runx2 pathway.
pharmacology & pharmacy,chemistry, medicinal,integrative & complementary medicine,plant sciences